Surge in Options Trading: Moderna, Meta, and Netflix Show Strong Activity
Options Volume Highlights for Major S&P 500 Players
Today, there has been significant options trading related to stocks in the S&P 500 index, particularly Moderna Inc (Symbol: MRNA). So far, 163,416 contracts have changed hands, which translates to about 16.3 million underlying shares. This volume represents an impressive 188.8% of MRNA’s average daily trading volume over the past month, which is 8.7 million shares. Notably, the $38 strike call option set to expire on January 17, 2025, saw 16,924 contracts traded, equating to approximately 1.7 million underlying shares of MRNA. Below is MRNA’s trailing twelve-month trading history with the highlighted $38 strike shown in orange:
Meanwhile, Meta Platforms Inc (Symbol: META) experienced a trading volume of 208,038 contracts, which corresponds to about 20.8 million underlying shares. This figure represents roughly 163.9% of META’s average daily trading volume of 12.7 million shares over the past month. The $650 strike call option expiring on January 17, 2025, attracted notable interest with 8,342 contracts traded today, amounting to approximately 834,200 underlying shares of META. Below is a chart depicting META’s trading history, highlighting the $650 strike:
In addition, options for Netflix Inc (Symbol: NFLX) recorded a volume of 43,466 contracts, representing around 4.3 million underlying shares. This total is approximately 153.2% of NFLX’s average daily trading volume of 2.8 million shares in the past month. The $800 strike put option expiring on January 17, 2025, saw significant activity with 2,008 contracts traded, which translates to about 200,800 underlying shares. Below is NFLX’s twelve-month trading history featuring the $800 strike:
For more information on available expiration options for MRNA, META, or NFLX, you can visit StockOptionsChannel.com.
Today’s Most Active Call & Put Options of the S&P 500 »
Additional Resources:
- PLCM Historical Stock Prices
- CCX Options Chain
- REW Historical Stock Prices
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
